In line with these results, we show that KRAS knock-down leads to reduced UHRF1 mRNA and protein expression in human KRAS mutant lung cancer cell lines (Supplementary Fig. 3c, d and Supplementary Fig. 4e). The gene discussed is KRAS; the disease is lung cancer.